nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—NQO1—lung cancer	0.211	0.437	CbGaD
Menadione—CYP2A6—lung cancer	0.113	0.234	CbGaD
Menadione—CYP2E1—lung cancer	0.0801	0.166	CbGaD
Menadione—CYP1A1—lung cancer	0.0791	0.164	CbGaD
Menadione—NQO1—Cisplatin—lung cancer	0.0778	0.229	CbGbCtD
Menadione—NQO1—Doxorubicin—lung cancer	0.0521	0.154	CbGbCtD
Menadione—MTHFR—Methotrexate—lung cancer	0.0459	0.136	CbGbCtD
Menadione—XDH—Cisplatin—lung cancer	0.0407	0.12	CbGbCtD
Menadione—AOX1—Methotrexate—lung cancer	0.0305	0.0901	CbGbCtD
Menadione—XDH—Doxorubicin—lung cancer	0.0272	0.0804	CbGbCtD
Menadione—CYP1A1—Gefitinib—lung cancer	0.0272	0.0803	CbGbCtD
Menadione—CYP1A1—Erlotinib—lung cancer	0.0161	0.0475	CbGbCtD
Menadione—CYP2E1—Etoposide—lung cancer	0.009	0.0265	CbGbCtD
Menadione—CYP1A2—Erlotinib—lung cancer	0.00719	0.0212	CbGbCtD
Menadione—CYP1A2—Etoposide—lung cancer	0.0052	0.0153	CbGbCtD
Menadione—F7—respiratory system—lung cancer	0.00251	0.0417	CbGeAlD
Menadione—F9—respiratory system—lung cancer	0.0024	0.0399	CbGeAlD
Menadione—VKORC1L1—respiratory system—lung cancer	0.00237	0.0393	CbGeAlD
Menadione—F9—epithelium—lung cancer	0.002	0.0333	CbGeAlD
Menadione—VKORC1L1—bronchus—lung cancer	0.00195	0.0324	CbGeAlD
Menadione—F10—mammary gland—lung cancer	0.00192	0.0319	CbGeAlD
Menadione—VKORC1L1—trachea—lung cancer	0.00175	0.0291	CbGeAlD
Menadione—PROC—bone marrow—lung cancer	0.00168	0.0279	CbGeAlD
Menadione—VKORC1L1—cardiac atrium—lung cancer	0.00164	0.0273	CbGeAlD
Menadione—F2—mammary gland—lung cancer	0.00137	0.0227	CbGeAlD
Menadione—MTHFR—mammary gland—lung cancer	0.00137	0.0227	CbGeAlD
Menadione—PROS1—respiratory system—lung cancer	0.00136	0.0226	CbGeAlD
Menadione—F7—lung—lung cancer	0.00133	0.0222	CbGeAlD
Menadione—F9—lung—lung cancer	0.00127	0.0212	CbGeAlD
Menadione—VKORC1L1—lung—lung cancer	0.00126	0.0209	CbGeAlD
Menadione—PROS1—Vinblastine—Vinorelbine—lung cancer	0.00125	0.438	CbGdCrCtD
Menadione—VKORC1—respiratory system—lung cancer	0.00123	0.0204	CbGeAlD
Menadione—GGCX—bronchus—lung cancer	0.00118	0.0196	CbGeAlD
Menadione—NQO1—mammary gland—lung cancer	0.00114	0.019	CbGeAlD
Menadione—PROS1—bronchus—lung cancer	0.00112	0.0186	CbGeAlD
Menadione—PROS1—trachea—lung cancer	0.001	0.0167	CbGeAlD
Menadione—PROS1—cardiac atrium—lung cancer	0.000943	0.0157	CbGeAlD
Menadione—F2—respiratory system—lung cancer	0.000911	0.0152	CbGeAlD
Menadione—MTHFR—respiratory system—lung cancer	0.000911	0.0152	CbGeAlD
Menadione—NQO1—Vincristine—Vinorelbine—lung cancer	0.000891	0.313	CbGdCrCtD
Menadione—F10—cardiac atrium—lung cancer	0.000888	0.0148	CbGeAlD
Menadione—VKORC1L1—lymph node—lung cancer	0.000859	0.0143	CbGeAlD
Menadione—BGLAP—bone marrow—lung cancer	0.000859	0.0143	CbGeAlD
Menadione—PROS1—bone marrow—lung cancer	0.000796	0.0132	CbGeAlD
Menadione—F2—epithelium—lung cancer	0.000761	0.0127	CbGeAlD
Menadione—NQO1—respiratory system—lung cancer	0.00076	0.0126	CbGeAlD
Menadione—GGCX—lung—lung cancer	0.00076	0.0126	CbGeAlD
Menadione—MTHFR—bronchus—lung cancer	0.00075	0.0125	CbGeAlD
Menadione—NQO2—bronchus—lung cancer	0.000747	0.0124	CbGeAlD
Menadione—PROS1—lung—lung cancer	0.000721	0.012	CbGeAlD
Menadione—NQO1—Vincristine—Vinblastine—lung cancer	0.000713	0.25	CbGdCrCtD
Menadione—F10—lung—lung cancer	0.000679	0.0113	CbGeAlD
Menadione—NQO2—trachea—lung cancer	0.000671	0.0112	CbGeAlD
Menadione—VKORC1—lung—lung cancer	0.000651	0.0108	CbGeAlD
Menadione—NQO1—epithelium—lung cancer	0.000635	0.0106	CbGeAlD
Menadione—NQO2—cardiac atrium—lung cancer	0.00063	0.0105	CbGeAlD
Menadione—NQO1—bronchus—lung cancer	0.000625	0.0104	CbGeAlD
Menadione—AOX1—bronchus—lung cancer	0.000574	0.00954	CbGeAlD
Menadione—Thalidomide—CYP2E1—lung cancer	0.000567	0.384	CrCbGaD
Menadione—NQO1—trachea—lung cancer	0.000562	0.00934	CbGeAlD
Menadione—Thalidomide—CYP1A1—lung cancer	0.000559	0.379	CrCbGaD
Menadione—MAOB—respiratory system—lung cancer	0.000537	0.00893	CbGeAlD
Menadione—F2—bone marrow—lung cancer	0.000534	0.00888	CbGeAlD
Menadione—NQO2—bone marrow—lung cancer	0.000532	0.00885	CbGeAlD
Menadione—GGCX—lymph node—lung cancer	0.000519	0.00864	CbGeAlD
Menadione—AOX1—trachea—lung cancer	0.000515	0.00857	CbGeAlD
Menadione—PROS1—lymph node—lung cancer	0.000493	0.0082	CbGeAlD
Menadione—AOX1—cardiac atrium—lung cancer	0.000484	0.00805	CbGeAlD
Menadione—F2—lung—lung cancer	0.000484	0.00804	CbGeAlD
Menadione—MTHFR—lung—lung cancer	0.000484	0.00804	CbGeAlD
Menadione—NQO2—lung—lung cancer	0.000482	0.00801	CbGeAlD
Menadione—F10—lymph node—lung cancer	0.000464	0.00772	CbGeAlD
Menadione—VKORC1—lymph node—lung cancer	0.000445	0.0074	CbGeAlD
Menadione—MAOB—bronchus—lung cancer	0.000442	0.00735	CbGeAlD
Menadione—NQO1—lung—lung cancer	0.000403	0.00671	CbGeAlD
Menadione—CYP2A6—lung—lung cancer	0.000387	0.00643	CbGeAlD
Menadione—CYP1A2—respiratory system—lung cancer	0.000382	0.00636	CbGeAlD
Menadione—CYP1A1—respiratory system—lung cancer	0.000377	0.00627	CbGeAlD
Menadione—MAOB—cardiac atrium—lung cancer	0.000373	0.0062	CbGeAlD
Menadione—AOX1—lung—lung cancer	0.00037	0.00616	CbGeAlD
Menadione—Thalidomide—PTGS2—lung cancer	0.00035	0.237	CrCbGaD
Menadione—CYP2E1—respiratory system—lung cancer	0.000344	0.00572	CbGeAlD
Menadione—MTHFR—lymph node—lung cancer	0.000331	0.0055	CbGeAlD
Menadione—NQO2—lymph node—lung cancer	0.00033	0.00548	CbGeAlD
Menadione—CYP1A1—epithelium—lung cancer	0.000315	0.00524	CbGeAlD
Menadione—CYP1A1—bronchus—lung cancer	0.00031	0.00516	CbGeAlD
Menadione—MAOB—lung—lung cancer	0.000285	0.00474	CbGeAlD
Menadione—CYP1A1—trachea—lung cancer	0.000279	0.00464	CbGeAlD
Menadione—NQO1—lymph node—lung cancer	0.000276	0.00459	CbGeAlD
Menadione—CYP1A1—cardiac atrium—lung cancer	0.000262	0.00435	CbGeAlD
Menadione—AOX1—lymph node—lung cancer	0.000253	0.00421	CbGeAlD
Menadione—CYP1A2—lung—lung cancer	0.000203	0.00338	CbGeAlD
Menadione—CYP1A1—lung—lung cancer	0.0002	0.00333	CbGeAlD
Menadione—MAOB—lymph node—lung cancer	0.000195	0.00324	CbGeAlD
Menadione—CYP2E1—lung—lung cancer	0.000183	0.00304	CbGeAlD
Menadione—CYP1A1—lymph node—lung cancer	0.000137	0.00228	CbGeAlD
Menadione—CYP2A6—Metabolism—CYP2E1—lung cancer	4.78e-06	4.22e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB3—lung cancer	4.77e-06	4.21e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—STAT3—lung cancer	4.73e-06	4.18e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—NQO1—lung cancer	4.73e-06	4.18e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ADCY1—lung cancer	4.73e-06	4.18e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ABCG2—lung cancer	4.73e-06	4.18e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—NRAS—lung cancer	4.72e-06	4.17e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ALDOA—lung cancer	4.72e-06	4.17e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CB—lung cancer	4.66e-06	4.11e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—HPGDS—lung cancer	4.64e-06	4.1e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ENO2—lung cancer	4.64e-06	4.1e-05	CbGpPWpGaD
Menadione—AOX1—Disease—STAT3—lung cancer	4.62e-06	4.08e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PTGS2—lung cancer	4.62e-06	4.08e-05	CbGpPWpGaD
Menadione—AOX1—Disease—NRAS—lung cancer	4.61e-06	4.07e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PPP2R1B—lung cancer	4.61e-06	4.07e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP2A7—lung cancer	4.6e-06	4.06e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL2—lung cancer	4.59e-06	4.05e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NCOA3—lung cancer	4.58e-06	4.05e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TERT—lung cancer	4.57e-06	4.04e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—MAPK3—lung cancer	4.52e-06	3.99e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.5e-06	3.98e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SDC4—lung cancer	4.5e-06	3.98e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GSTT1—lung cancer	4.5e-06	3.97e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTEN—lung cancer	4.49e-06	3.96e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ABCG2—lung cancer	4.46e-06	3.94e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ADCY1—lung cancer	4.46e-06	3.94e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP2A6—lung cancer	4.45e-06	3.93e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GCLC—lung cancer	4.45e-06	3.93e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FGFR1—lung cancer	4.44e-06	3.92e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTEN—lung cancer	4.43e-06	3.91e-05	CbGpPWpGaD
Menadione—AOX1—Disease—MAPK3—lung cancer	4.42e-06	3.9e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—MYC—lung cancer	4.4e-06	3.88e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HIF1A—lung cancer	4.37e-06	3.86e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—HPGDS—lung cancer	4.37e-06	3.86e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ENO2—lung cancer	4.37e-06	3.86e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PPP2R1B—lung cancer	4.34e-06	3.84e-05	CbGpPWpGaD
Menadione—F2—Hemostasis—AKT1—lung cancer	4.34e-06	3.83e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTEN—lung cancer	4.33e-06	3.82e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—EGFR—lung cancer	4.3e-06	3.8e-05	CbGpPWpGaD
Menadione—AOX1—Disease—MYC—lung cancer	4.3e-06	3.79e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.29e-06	3.79e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—EP300—lung cancer	4.28e-06	3.78e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—STK11—lung cancer	4.26e-06	3.77e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GSTT1—lung cancer	4.24e-06	3.74e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CB—lung cancer	4.23e-06	3.74e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—EP300—lung cancer	4.23e-06	3.73e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—APOA1—lung cancer	4.22e-06	3.73e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ENO1—lung cancer	4.21e-06	3.72e-05	CbGpPWpGaD
Menadione—AOX1—Disease—EGFR—lung cancer	4.2e-06	3.71e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTGS2—lung cancer	4.2e-06	3.7e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP2A6—lung cancer	4.19e-06	3.7e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GCLC—lung cancer	4.19e-06	3.7e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KDR—lung cancer	4.18e-06	3.69e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.18e-06	3.69e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—EP300—lung cancer	4.13e-06	3.65e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—RRM1—lung cancer	4.1e-06	3.62e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTA3—lung cancer	4.1e-06	3.62e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—KRAS—lung cancer	4.07e-06	3.59e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PTEN—lung cancer	4.03e-06	3.55e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ENO1—lung cancer	3.97e-06	3.51e-05	CbGpPWpGaD
Menadione—AOX1—Disease—KRAS—lung cancer	3.97e-06	3.51e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.96e-06	3.5e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—GSTP1—lung cancer	3.95e-06	3.48e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.91e-06	3.45e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—B4GALT5—lung cancer	3.86e-06	3.4e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—APC—lung cancer	3.85e-06	3.4e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KIT—lung cancer	3.85e-06	3.4e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CG—lung cancer	3.85e-06	3.4e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NRAS—lung cancer	3.85e-06	3.4e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—EP300—lung cancer	3.84e-06	3.39e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CAT—lung cancer	3.84e-06	3.39e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EGF—lung cancer	3.81e-06	3.36e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTA4—lung cancer	3.75e-06	3.31e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NQO1—lung cancer	3.74e-06	3.3e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—PIK3CA—lung cancer	3.73e-06	3.3e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ABCB1—lung cancer	3.73e-06	3.3e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—MAPK3—lung cancer	3.69e-06	3.26e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—TYMS—lung cancer	3.67e-06	3.24e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—POMC—lung cancer	3.67e-06	3.24e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.67e-06	3.24e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTEN—lung cancer	3.66e-06	3.23e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTA2—lung cancer	3.66e-06	3.23e-05	CbGpPWpGaD
Menadione—AOX1—Disease—PIK3CA—lung cancer	3.65e-06	3.22e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—GSTM1—lung cancer	3.63e-06	3.2e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—BRAF—lung cancer	3.62e-06	3.2e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6R—lung cancer	3.58e-06	3.16e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CREBBP—lung cancer	3.57e-06	3.15e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP2E1—lung cancer	3.56e-06	3.15e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTA1—lung cancer	3.53e-06	3.11e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NQO1—lung cancer	3.52e-06	3.11e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—EGFR—lung cancer	3.51e-06	3.1e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—EP300—lung cancer	3.49e-06	3.08e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ABCC3—lung cancer	3.49e-06	3.08e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—HRAS—lung cancer	3.46e-06	3.05e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.45e-06	3.05e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP1A1—lung cancer	3.44e-06	3.03e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.42e-06	3.02e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MAP2K1—lung cancer	3.41e-06	3.01e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ERCC2—lung cancer	3.41e-06	3.01e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CD—lung cancer	3.39e-06	2.99e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKR1C1—lung cancer	3.38e-06	2.98e-05	CbGpPWpGaD
Menadione—AOX1—Disease—HRAS—lung cancer	3.38e-06	2.98e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—STK11—lung cancer	3.37e-06	2.98e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PIK3CA—lung cancer	3.36e-06	2.96e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—KRAS—lung cancer	3.32e-06	2.93e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—IL6—lung cancer	3.31e-06	2.92e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—UGT1A1—lung cancer	3.28e-06	2.9e-05	CbGpPWpGaD
Menadione—AOX1—Disease—IL6—lung cancer	3.23e-06	2.85e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—STK11—lung cancer	3.18e-06	2.81e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—PIK3CA—lung cancer	3.17e-06	2.8e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GNG11—lung cancer	3.16e-06	2.79e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.15e-06	2.78e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PIK3CA—lung cancer	3.13e-06	2.76e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GSTP1—lung cancer	3.12e-06	2.75e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—PIK3CA—lung cancer	3.06e-06	2.7e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—AKT1—lung cancer	3.05e-06	2.69e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PIK3CA—lung cancer	3.05e-06	2.69e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MDM2—lung cancer	3.03e-06	2.68e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CAT—lung cancer	3.03e-06	2.68e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RAF1—lung cancer	3.02e-06	2.67e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ALDOA—lung cancer	3.01e-06	2.66e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB2—lung cancer	2.99e-06	2.64e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.98e-06	2.63e-05	CbGpPWpGaD
Menadione—AOX1—Disease—AKT1—lung cancer	2.98e-06	2.63e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MTOR—lung cancer	2.95e-06	2.61e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CB—lung cancer	2.95e-06	2.61e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ABCB1—lung cancer	2.95e-06	2.61e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—APOA1—lung cancer	2.95e-06	2.6e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GSTP1—lung cancer	2.94e-06	2.6e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NCOA3—lung cancer	2.92e-06	2.58e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—TYMS—lung cancer	2.9e-06	2.56e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.87e-06	2.54e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GSTM1—lung cancer	2.87e-06	2.53e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CAT—lung cancer	2.86e-06	2.53e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.84e-06	2.51e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ADCY1—lung cancer	2.84e-06	2.51e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ABCG2—lung cancer	2.84e-06	2.51e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CA—lung cancer	2.84e-06	2.51e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CXCL8—lung cancer	2.84e-06	2.51e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRAS—lung cancer	2.82e-06	2.49e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ENO2—lung cancer	2.79e-06	2.46e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—HPGDS—lung cancer	2.79e-06	2.46e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ABCB1—lung cancer	2.78e-06	2.46e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.77e-06	2.45e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—AKT1—lung cancer	2.74e-06	2.42e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.73e-06	2.41e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—TYMS—lung cancer	2.73e-06	2.41e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP1A1—lung cancer	2.72e-06	2.4e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CASP3—lung cancer	2.72e-06	2.4e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL2—lung cancer	2.71e-06	2.39e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTT1—lung cancer	2.7e-06	2.39e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GSTM1—lung cancer	2.7e-06	2.39e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL6—lung cancer	2.7e-06	2.38e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ERCC2—lung cancer	2.69e-06	2.38e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CG—lung cancer	2.69e-06	2.38e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GCLC—lung cancer	2.67e-06	2.36e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP2A6—lung cancer	2.67e-06	2.36e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.66e-06	2.35e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCND1—lung cancer	2.64e-06	2.33e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—JUN—lung cancer	2.64e-06	2.33e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—AKT1—lung cancer	2.59e-06	2.28e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CA—lung cancer	2.58e-06	2.28e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MMP9—lung cancer	2.57e-06	2.27e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—POMC—lung cancer	2.56e-06	2.26e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CDKN1A—lung cancer	2.56e-06	2.26e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—AKT1—lung cancer	2.56e-06	2.26e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTEN—lung cancer	2.55e-06	2.25e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ERCC2—lung cancer	2.54e-06	2.24e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ENO1—lung cancer	2.53e-06	2.24e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.52e-06	2.23e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CREBBP—lung cancer	2.5e-06	2.2e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—AKT1—lung cancer	2.5e-06	2.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.49e-06	2.2e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AKT1—lung cancer	2.49e-06	2.2e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EP300—lung cancer	2.43e-06	2.15e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CD—lung cancer	2.37e-06	2.09e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SRC—lung cancer	2.37e-06	2.09e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ALB—lung cancer	2.34e-06	2.06e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—APOA1—lung cancer	2.33e-06	2.06e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—AKT1—lung cancer	2.32e-06	2.05e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—VEGFA—lung cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—STAT3—lung cancer	2.28e-06	2.01e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRAS—lung cancer	2.28e-06	2.01e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP2E1—lung cancer	2.27e-06	2.01e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NQO1—lung cancer	2.25e-06	1.98e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.2e-06	1.94e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—APOA1—lung cancer	2.2e-06	1.94e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.18e-06	1.93e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MAPK3—lung cancer	2.18e-06	1.92e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CG—lung cancer	2.13e-06	1.88e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MYC—lung cancer	2.12e-06	1.87e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—AKT1—lung cancer	2.11e-06	1.86e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.1e-06	1.86e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EGFR—lung cancer	2.07e-06	1.83e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CB—lung cancer	2.06e-06	1.82e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTGS2—lung cancer	2.04e-06	1.8e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—STK11—lung cancer	2.03e-06	1.79e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—POMC—lung cancer	2.03e-06	1.79e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CG—lung cancer	2.01e-06	1.77e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CREBBP—lung cancer	1.97e-06	1.74e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KRAS—lung cancer	1.96e-06	1.73e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—POMC—lung cancer	1.91e-06	1.69e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTP1—lung cancer	1.87e-06	1.65e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CD—lung cancer	1.87e-06	1.65e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CREBBP—lung cancer	1.86e-06	1.64e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ALB—lung cancer	1.85e-06	1.63e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CAT—lung cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.81e-06	1.6e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CA—lung cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTEN—lung cancer	1.78e-06	1.57e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ABCB1—lung cancer	1.77e-06	1.57e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CD—lung cancer	1.76e-06	1.56e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—TYMS—lung cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—lung cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ALB—lung cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTM1—lung cancer	1.72e-06	1.52e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—EP300—lung cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRAS—lung cancer	1.67e-06	1.47e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP1A1—lung cancer	1.63e-06	1.44e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CB—lung cancer	1.63e-06	1.44e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ERCC2—lung cancer	1.62e-06	1.43e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTGS2—lung cancer	1.62e-06	1.43e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6—lung cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CB—lung cancer	1.54e-06	1.36e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTGS2—lung cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKT1—lung cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTEN—lung cancer	1.41e-06	1.24e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—APOA1—lung cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—EP300—lung cancer	1.34e-06	1.19e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.34e-06	1.18e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTEN—lung cancer	1.33e-06	1.17e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CG—lung cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—EP300—lung cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CA—lung cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—POMC—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CREBBP—lung cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CD—lung cancer	1.12e-06	9.93e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ALB—lung cancer	1.11e-06	9.8e-06	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKT1—lung cancer	1.03e-06	9.07e-06	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CA—lung cancer	9.94e-07	8.77e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CB—lung cancer	9.8e-07	8.65e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTGS2—lung cancer	9.71e-07	8.57e-06	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CA—lung cancer	9.37e-07	8.27e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTEN—lung cancer	8.47e-07	7.48e-06	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKT1—lung cancer	8.12e-07	7.17e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—EP300—lung cancer	8.08e-07	7.13e-06	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKT1—lung cancer	7.65e-07	6.76e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CA—lung cancer	5.97e-07	5.28e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKT1—lung cancer	4.88e-07	4.31e-06	CbGpPWpGaD
